Capturing Parkinson's Disease Medication Side Effects During Daily Activities

Phase I Study: Monitoring Levodopa-Induced Dyskinesia Using Accelerometer & Gyroscope-based Motion Detection System

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01429207

Enrollment

Registered

2011-09-07

Start date

2011-08-31

Completion date

Unknown

Last updated

2012-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyskinesia, Parkinson's Disease

Keywords

levodopa, tremor, bradykinesia, motion sensors

Brief summary

The purpose of the study is to test whether body-worn wireless motion sensors can measure dyskinesias (involuntary movements caused by medications) in individuals with Parkinson disease (PD) independent of voluntary activity being performed and other PD motor symptoms (e.g. tremor).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of probable or definite idiopathic Parkinson Disease with motor fluctuations that include dyskinesias after taking their usual dose of levodopa/carbidopa

Exclusion criteria

* Antipsychotic medications (including quetiapine and clozapine) * Coexisting neurologic disease such as stroke or dementia * Lacking capacity for informed consent * Residing in a nursing home * comorbid non-neurologic illnesses that impacts the ability to perform the study tasks * Implantable defibrillators

Countries

United States

Outcome results